Fixing Claude with Claude: Anthropic reports on AI site reliability engineering

QCon London A member of Anthropic's AI reliability engineering team spoke at QCon London on why Claude excels at finding ...
CIO

What happens if SAP’s S/4HANA roadmap doesn’t suit?

Pushed toward adopting S/4HANA, CIOs have options, whether it’s modernizing around ECC, adopting a composable architecture to ...

Oracle Is Soaring After Blowout Earnings. 3 Reasons to Buy the Stock (and 1 Reason to Avoid It).

Oracle's artificial intelligence (AI) strategy is risky, but could pay off big time.

Oracle Is Burning Cash in the Pursuit of "Hypergrowth." Is the AI Growth Stock a Buy Anyway?

Oracle's impeccable results come at a high price.

Oracle stock up 10% after earnings: why analysts are cutting targets

Ader reiterated an Overweight rating on Oracle shares with a price target of $300. Some analysts adjusted their outlooks ...
Becker's Hospital Review

Oracle Health launches AI clinical note tool for inpatient, ED settings

Oracle Health launches clinical AI note tool to reduce documentation time and streamline workflows in inpatient and emergency department settings.
Yahoo Finance

Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...
Yahoo Finance

Oracle (ORCL) Registers a Bigger Fall Than the Market: Important Facts to Note

Oracle (ORCL) closed at $146.67 in the latest trading session, marking a -5.17% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. At the same ...